We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

45 hedge funds and large institutions have $3.13M invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

2% more funds holding

Funds holding: 44 → 45 (+1)

1% more capital invested

Capital invested by funds: $3.1M → $3.13M (+$27.7K)

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$33.1K
2
Goldman Sachs
Goldman Sachs
New York
+$23K
3
Stifel Financial
Stifel Financial
Missouri
+$13.3K
4
Renaissance Technologies
Renaissance Technologies
New York
+$12.3K
5
HNB
Huntington National Bank
Ohio
+$10.3K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$241K
2
Citadel Advisors
Citadel Advisors
Florida
-$31.8K
3
LPL Financial
LPL Financial
California
-$22.5K
4
Millennium Management
Millennium Management
New York
-$15K
5
AIG
American International Group
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
26
Virtu KCG Holdings
New York
$6K -$3.2K -8,419 -33%
ACM
27
Academy Capital Management
Texas
$6K – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$6K – – –
BA
29
BlackRock Advisors
Delaware
$5K – – –
FCI
30
Financial Counselors Inc
Kansas
$5K – – –
TSS
31
Two Sigma Securities
New York
$4K -$3.94K -10,345 -47%
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$4K -$2.28K -6,000 -34%
EC
33
Estate Counselors
Wisconsin
$4K – – –
FAAS
34
First Allied Advisory Services
California
$4K – – –
PCM
35
Princeton Capital Management
New Jersey
$4K – – –
FWM
36
Focused Wealth Management
New York
$1K – – –
GT
37
Glenmede Trust
Pennsylvania
$1K – – –
Millennium Management
38
Millennium Management
New York
– -$15K -39,760 Closed
AIG
39
American International Group
New York
– -$9K -23,650 Closed
Citigroup
40
Citigroup
New York
– -$761 -2,000 -67%
BIG
41
Bellwether Investment Group
Tennessee
– +$133 +350 New
JCM
42
Jacobi Capital Management
Pennsylvania
– +$380 +1,000 New
LTFS
43
Ladenburg Thalmann Financial Services
Florida
– +$380 +1,000 +75%
1
2

PVCT Hedge Fund Activity: Q2 2016 in Review

45 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q2 2016, worth a combined $3.13M — up 0.89% from $3.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PVCT positions and 3 closed out — a net gain of 1 holder — while 13 added to existing stakes and 7 trimmed.

The largest buyer was UBS Group, adding an estimated $33.1K. The largest seller was Sabby Management, cutting an estimated $241K.

  • 45 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q2 2016, up from 44 in Q1 2016.
  • Funds reported $3.13M of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q2 2016, up 0.89% quarter-over-quarter.
  • 4 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q2 2016 and 3 closed out, a net change of +1 holder.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q2 2016 was UBS Group, an estimated $33.1K added.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) seller in Q2 2016 was Sabby Management, an estimated $241K sold.

Based on aggregated 13F filings for Q2 2016.